pLTR-RD114A Citations (15)

Originally described in: Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins.
Zhang XY, La Russa VF, Reiser J J Virol. 2004 Feb . 78(3):1219-29. PubMed Journal

---

Articles Citing pLTR-RD114A

Articles
Improved GaLV-TR Glycoproteins to Pseudotype Lentiviral Vectors: Impact of Viral Protease Activity in the Production of LV Pseudotypes. Tomas HA, Mestre DA, Rodrigues AF, Guerreiro MR, Carrondo MJT, Coroadinha AS. Mol Ther Methods Clin Dev. 2019 Aug 14;15:1-8. doi: 10.1016/j.omtm.2019.08.001. eCollection 2019 Dec 13. PubMed
Efficient and Robust NK-Cell Transduction With Baboon Envelope Pseudotyped Lentivector. Colamartino ABL, Lemieux W, Bifsha P, Nicoletti S, Chakravarti N, Sanz J, Romero H, Selleri S, Beland K, Guiot M, Tremblay-Laganiere C, Dicaire R, Barreiro L, Lee DA, Verhoeyen E, Haddad E. Front Immunol. 2019 Dec 16;10:2873. doi: 10.3389/fimmu.2019.02873. eCollection 2019. PubMed
HDAC6 Regulates Radiosensitivity of Non-Small Cell Lung Cancer by Promoting Degradation of Chk1. Moses N, Zhang M, Wu JY, Hu C, Xiang S, Geng X, Chen Y, Bai W, Zhang YW, Bepler G, Zhang XM. Cells. 2020 Oct 4;9(10). pii: cells9102237. doi: 10.3390/cells9102237. PubMed
Nano-optogenetic engineering of CAR T cells for precision immunotherapy with enhanced safety. Nguyen NT, Huang K, Zeng H, Jing J, Wang R, Fang S, Chen J, Liu X, Huang Z, You MJ, Rao A, Huang Y, Han G, Zhou Y. Nat Nanotechnol. 2021 Dec;16(12):1424-1434. doi: 10.1038/s41565-021-00982-5. Epub 2021 Oct 25. PubMed
Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells. Anadon CM, Yu X, Hanggi K, Biswas S, Chaurio RA, Martin A, Payne KK, Mandal G, Innamarato P, Harro CM, Mine JA, Sprenger KB, Cortina C, Powers JJ, Costich TL, Perez BA, Gatenbee CD, Prabhakaran S, Marchion D, Heemskerk MHM, Curiel TJ, Anderson AR, Wenham RM, Rodriguez PC, Conejo-Garcia JR. Cancer Cell. 2022 May 9;40(5):545-557.e13. doi: 10.1016/j.ccell.2022.03.008. Epub 2022 Apr 14. PubMed
Olfactory Receptor OR2H1 Is an Effective Target for CAR T Cells in Human Epithelial Tumors. Martin AL, Anadon CM, Biswas S, Mine JA, Handley KF, Payne KK, Mandal G, Chaurio RA, Powers JJ, Sprenger KB, Rigolizzo KE, Innamarato P, Harro CM, Mehta S, Perez BA, Wenham RM, Conejo-Garcia JR. Mol Cancer Ther. 2022 Jul 5;21(7):1184-1194. doi: 10.1158/1535-7163.MCT-21-0872. PubMed
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade. Palmer DC, Webber BR, Patel Y, Johnson MJ, Kariya CM, Lahr WS, Parkhurst MR, Gartner JJ, Prickett TD, Lowery FJ, Kishton RJ, Gurusamy D, Franco Z, Vodnala SK, Diers MD, Wolf NK, Slipek NJ, McKenna DH, Sumstad D, Viney L, Henley T, Burckstummer T, Baker O, Hu Y, Yan C, Meerzaman D, Padhan K, Lo W, Malekzadeh P, Jia L, Deniger DC, Patel SJ, Robbins PF, McIvor RS, Choudhry M, Rosenberg SA, Moriarity BS, Restifo NP. Med. 2022 Oct 14;3(10):682-704.e8. doi: 10.1016/j.medj.2022.07.008. Epub 2022 Aug 24. PubMed
T Cells Expressing CAR Equipped With Extracellular Domain of BTLA Are Effective Against HVEM-over-expressing Melanoma Cell Lines. Kim Y, Kim JE, Lee DY, Choi JU, Park JS, Lee HK, Choi SU, Park S, Park CH. Anticancer Res. 2023 Aug;43(8):3419-3427. doi: 10.21873/anticanres.16517. PubMed
Reactivated endogenous retroviruses promote protein aggregate spreading. Liu S, Heumuller SE, Hossinger A, Muller SA, Buravlova O, Lichtenthaler SF, Denner P, Vorberg IM. Nat Commun. 2023 Aug 18;14(1):5034. doi: 10.1038/s41467-023-40632-z. PubMed
Optimized peptide nanofibrils as efficient transduction enhancers for in vitro and ex vivo gene transfer. Rauch-Wirth L, Renner A, Kaygisiz K, Weil T, Zimmermann L, Rodriguez-Alfonso AA, Schutz D, Wiese S, Standker L, Weil T, Schmiedel D, Munch J. Front Immunol. 2023 Nov 9;14:1270243. doi: 10.3389/fimmu.2023.1270243. eCollection 2023. PubMed
Suppression of the METTL3-m(6)A-integrin beta1 axis by extracellular acidification impairs T cell infiltration and antitumor activity. Wang Z, Shang J, Qiu Y, Cheng H, Tao M, Xie E, Pei X, Li W, Zhang L, Wu A, Li G. Cell Rep. 2024 Feb 27;43(2):113796. doi: 10.1016/j.celrep.2024.113796. Epub 2024 Feb 16. PubMed
Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity. Qiu Y, Su Y, Xie E, Cheng H, Du J, Xu Y, Pan X, Wang Z, Chen DG, Zhu H, Greenberg PD, Li G. Cancer Cell. 2025 Jan 13;43(1):103-121.e8. doi: 10.1016/j.ccell.2024.11.003. Epub 2024 Dec 5. PubMed
Immunosequencing identifies signatures of T cell responses for early detection of nasopharyngeal carcinoma. Zhang S, Zhou Y, Liu Z, Wang Y, Zhou X, Chen H, Zhang X, Chen Y, Feng Q, Ye X, Xie S, Zeng MS, Zhai W, Zeng YX, Cao S, Li G, Xu M. Cancer Cell. 2025 May 6:S1535-6108(25)00168-0. doi: 10.1016/j.ccell.2025.04.009. PubMed
Succinate preserves CD8(+) T cell fitness to augment antitumor immunity. Ma K, Cheng H, Wang L, Xiao H, Liu F, Yang Y, Xiao Z, Tang K, Li S, Wang G, Ge M, Wang J, Liu X, Sun HX, Luo Z, Gu Z, Ho PC, Li G, Zhang L. Immunity. 2025 Oct 14;58(10):2505-2523.e8. doi: 10.1016/j.immuni.2025.07.017. Epub 2025 Aug 14. PubMed
Engineered T cells stimulate dendritic cell recruitment and antigen spreading for potent anti-tumor immunity. Xiao Z, Wang J, He S, Wang L, Yang J, Li W, Ma K, Zhou Y, Liu X, Wang S, Yang Y, Ge M, Gao A, Tang K, Huang J, Wang C, Zhang L, Sun HX, Zhang L. Cell Rep Med. 2025 Sep 16;6(9):102307. doi: 10.1016/j.xcrm.2025.102307. Epub 2025 Aug 25. PubMed

If you have published an article using this material, please email us at to have your article added to this page.